Is gravidity associated with COVID‐19 vaccination among pregnant women in Jamaica?
Reproductive, Female and Child Health · 2024
DOI: 10.1002/rfc2.100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive, Female and Child Health, 2024. Verfasst von Jodian A Pinkney und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Introduction
In 2021, Jamaica's maternal mortality ratio doubled as a result of COVID‐19‐related deaths. Yet, COVID‐19 vaccination among pregnant Jamaican women remained low. In the United States, COVID‐19 vaccination is lower among pregnant women who have had multiple pregnancies (multigravidas) versus women who were pregnant for the first time (primigravidas). We examined whether this pattern exists in Jamaica.
Methods
A cross‐sectional survey of a convenience sample of 79 pregnant Jamaican women recruited from a teaching hospital (May–July 2022) was used to assess self‐reported COVID‐19 vaccination and medical mistrust beliefs—operationalized as low vaccine confidence, government mistrust, and race‐based mistrust—by gravidity. We used modified Poisson regression to estimate adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for vaccination by gravidity, adjusting for age, education, and comorbidities.
Results
Thirty‐nine (49%) of the participants were multigravidas. Socioeconomic status was similar between multigravidas and primigravidas. COVID‐19 vaccination was lower in multigravidas (46%) than primigravidas (75%) after adjusting for age, education, and comorbidities (aPR = 0.67, 95% CI = 0.46–0.99; p = 0.044). Vaccine confidence was lower in multigravidas ( p = 0.044). Government mistrust and race‐based mistrust did not differ between the two groups.
Conclusion
In Jamaica, multigravidas may have lower COVID‐19 vaccine uptake and lower vaccine confidence compared with primigravidas. Understanding the distinct needs of pregnant subpopulations is essential for crafting effective maternal vaccination campaigns.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- RAND Corporation, Santa Monica, California, USA.
- Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
- University of the West Indies, Kingston, Jamaica, West Indies.
ORCID-Profile: Jodian A Pinkney
Förderung
- NIMH NIH HHS
- NIAID NIH HHS
Zitieren
APA
Pinkney, J. A., Bogart, L. M., Carroll, K. N., Bryan, L. R., Witter, G. A., Ashour, D., Hoeppner, S. S., Hurtado, R. M., Goldfarb, I. T., Psaros, C., Hyle, E. P., & Ojikutu, B. O. (2024). Is gravidity associated with COVID‐19 vaccination among pregnant women in Jamaica?. Reproductive, Female and Child Health. https://doi.org/10.1002/rfc2.100
Vancouver
Pinkney JA, Bogart LM, Carroll KN, Bryan LR, Witter GA, Ashour D, et al. Is gravidity associated with COVID‐19 vaccination among pregnant women in Jamaica?. Reproductive, Female and Child Health. 2024. doi:10.1002/rfc2.100
BibTeX
@article{Pinkney2024,
author = {Pinkney, Jodian A and Bogart, Laura M and Carroll, Kamali N and Bryan, Lenroy R and Witter, Givana A and Ashour, Dina and Hoeppner, Susanne S and Hurtado, Rocio M and Goldfarb, Ilona T and Psaros, Christina and Hyle, Emily P and Ojikutu, Bisola O},
title = {Is gravidity associated with COVID‐19 vaccination among pregnant women in Jamaica?},
journal = {Reproductive, Female and Child Health},
year = {2024},
doi = {10.1002/rfc2.100}
}
EUVIMED